2-(7-hydroxyheptyl)cyclopent-2-enone | 33803-57-5

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: 2-(7-hydroxyheptyl)cyclopent-2-enone
• 英文别名: 2-(7-Hydroxyheptyl)-2-cyclopenten-1-on；2-(7-Hydroxy-heptyl)-cyclopent-2-en-1-on；2-<7-Hydroxy-heptyl>-cyclopent-2-en-1-on；2-(7-Hydroxyheptyl)cyclopent-2-enon；2-(7-hydroxyheptyl)-2-cyclopenten-1-one；2-(7-hydroxyheptyl)cyclopent-2-en-1-one；2-(7-hydroxyheptyl)-2-cyclopentenone
• CAS: 33803-57-5
• 化学式: C₁₂H₂₀O₂
• 分子量: 196.29
• InChiKey: WDCKVVCOPDJIIB-UHFFFAOYSA-N

物化性质

• 沸点：
  333.4±31.0 °C(Predicted)
• 密度：
  1.011±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.5
• 重原子数：
  14
• 可旋转键数：
  7
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.75
• 拓扑面积：
  37.3
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  2-(7-hydroxyheptyl)cyclopent-2-enone 在 jones' reagent 作用下， 以 丙酮 为溶剂， 反应 0.5h， 以75%的产率得到5-氧代环戊-1-烯-1-庚酸
  参考文献：
  名称：

  Caton, Michael P. L.; Darnbrough, Geoffrey; Parker, Trevor, Journal of the Chemical Society. Perkin transactions I, 1983, p. 319 - 324

  摘要：

  DOI：
• 作为产物：
  描述：

  (10RS,11SR)-10,11,17-trihydroxy-heptadecanoic acid 生成 2-(7-hydroxyheptyl)cyclopent-2-enone
  参考文献：
  名称：

  Burton; Caton; Coffee, Journal of the Chemical Society. Perkin transactions I, 1976, # 23, p. 2550 - 2556

  摘要：

  DOI：

文献信息

• Cyclopentane derivatives
  申请人：May & Baker Limited

  公开号：US03935261A1

  公开（公告）日：1976-01-27

  Cyclopentane derivatives of the prostaglandin type of the formula: ##SPC1## (wherein R.sup.1 represents hydrogen or lower alkyl, R.sup.2 represents alkyl of 1 to 10 carbon atoms, the symbols R.sup.3 are the same and represent hydrogen, lower alkyl, lower alkenyl, phenyl(lower)alkyl or lower alkanoyl, R.sup.4 represents a carboxy or alkoxycarbonyl group, or an amido group unsubstituted or substituted on the nitrogen atom, X represents vinylene, ethylene, epoxyethylene or cyclopropylene, and n represents an integer of 5 to 8), which possess pharmacological properties in particular the production of hypotension, bronchodilation, inhibition of gastric acid secretion and stimulation of uterine contraction are prepared by a new six-stage process involving initially the reaction of an enamine of a cyclopentanone with an aldehyde to form a 2-hydroxyalkyl-2-cyclopenten-1-one, reacting the cyclopentenone with a source of hydrogen cyanide to form a hydroxyalkyl-3-oxocyclopentane-carbonitrile, reducing the carbonitrile to a 3-hydroxy-2-hydroxyalkyl-cyclopentanecarbaldehyde, reacting the carbaldehyde with an alkanoylmethylenephosphorane to convert the formyl group to ------CH=CH --CO--R.sup.2, oxidising the terminal hydroxymethyl group in the 2-position substituent to carboxy and the ring hydroxy group to oxo, and reducing the two oxo groups in the resulting cyclopentanonealkanoic acid to yield a 2-hydroxy-5-(3-hydroxyalkenyl)cyclopentyl-alkanoic acid, and optionally converting the product into another compound of the foregoing formula.

  环戊烷前列腺素类衍生物的化学式为：##SPC1##（其中R.sup.1代表氢或较低的烷基，R.sup.2代表1至10个碳原子的烷基，符号R.sup.3相同，代表氢、较低的烷基、较低的烯基、苯基（较低）烷基或较低的烷酰基，R.sup.4代表羧基或烷氧羰基，或未取代或在氮原子上取代的酰胺基团，X代表乙烯基、乙烯基、环氧乙烯基或环丙基，n代表5至8的整数），具有特定药理特性，特别是降压、支气管扩张、抑制胃酸分泌和促进子宫收缩的产生，通过一个新的六阶段过程制备，首先涉及环戊酮的烯胺与醛的反应形成2-羟基烷基-2-环戊烯-1-酮，将环戊烯酮与氰化氢源反应形成羟基烷基-3-氧代环戊烷-腈，将腈还原为3-羟基-2-羟基烷基-环戊醛，将醛与烷酰亚甲基膦烷反应将醛基转化为------CH=CH --CO--R.sup.2，将2-位置取代基的末端羟甲基基团氧化为羧基，将环羟基氧化为醛基，将所得环戊酮烷酸中的两个醛基还原为2-羟基-5-(3-羟基烯基)环戊基-烷酸，并可选择将产物转化为上述化学式的另一化合物。
• Cyclopentanone derivatives
  申请人：May & Baker Limited

  公开号：US04088695A1

  公开（公告）日：1978-05-09

  Cyclopentane derivatives of the formula: ##STR1## wherein R.sup.1 represents hydrogen or a carboxylic acyl group, and either (I) R.sup.2 represents a group of the formula: --CR.sup.3 R.sup.4 R.sup.5 II (wherein R.sup.3 and R.sup.4 represent hydrogen or alkyl, and R.sup.5 represents hydrogen, or alkyl, alkoxy, cycloalkyl or adamantyl, or R.sup.5 represents alkyl substituted by alkoxy, or by cycloalkyl or by adamantyl, or the group --CR.sup.3 R.sup.4 R.sup.5 together forms a cycloalkyl or adamantyl group), X represents trans-vinylene or ethylene and Y represents carbonyl or a group of the formula: ##STR2## wherein R.sup.6 represents hydrogen or alkyl, and R.sup.7 represents hydrogen or a carboxylic acyl group, or else (ii) R.sup.2 represents a group of the formula: --A-Z-R.sup.8 IV (wherein A represents alkylene, Z represents a direct bond or oxygen or sulphur, and R.sup.8 represents an aryl or heterocyclyl group which may be substituted by one or more of halogen, alkyl, alkoxy and trihalomethyl), X in formula I represents ethylene or trans-vinylene and Y in formula I represents carbonyl or a group of formula III, or else (iii) R.sup.2 represents a group R.sup.8 and X and Y in formula I represent simultaneously ethylene and carbonyl, trans-vinylene and carbonyl, or ethylene and --CH(OR.sup.7)-- groups respectively. The compounds are new and possess pharmacological properties similar to those of prostaglandins.

  环戊烷衍生物的化学式：##STR1## 其中R.sup.1代表氢或羧酰基团，且（I）R.sup.2代表化学式的一个基团：--CR.sup.3 R.sup.4 R.sup.5 II（其中R.sup.3和R.sup.4代表氢或烷基，R.sup.5代表氢、烷基、烷氧基、环烷基或脱氢脂肪基，或R.sup.5代表烷基被烷氧基、环烷基或脱氢脂肪基取代，或基团--CR.sup.3 R.sup.4 R.sup.5共同形成环烷基或脱氢脂肪基），X代表反式-乙烯基或乙烯基，Y代表羰基或化学式的一个基团：##STR2## 其中R.sup.6代表氢或烷基，R.sup.7代表氢或羧酰基团，或者（ii）R.sup.2代表化学式的一个基团：--A-Z-R.sup.8 IV（其中A代表烷基，Z代表直接键或氧或硫，R.sup.8代表可能被卤素、烷基、烷氧基和三卤甲基中的一个或多个取代的芳基或杂环烷基），化学式I中的X代表乙烯基或反式-乙烯基，化学式I中的Y代表羰基或化学式III的一个基团，或者（iii）R.sup.2代表基团R.sup.8，化学式I中的X和Y同时代表乙烯基和羰基、反式-乙烯基和羰基，或乙烯基和--CH(OR.sup.7)--基团。这些化合物是新的，具有类似于前列腺素的药理特性。
• 1 And 2-substituted analogues of certain prostaglandins
  申请人：Miles Laboratories, Inc.

  公开号：US04171331A1

  公开（公告）日：1979-10-16

  Disclosed are trans 1 & 2-di(loweralkyl)phosphono; 1 & 2-chloro, bromo and iodo; 1 & 2-thio and 1 & 2-amino analogues of E.sub.1, A.sub.1, F.sub.1.alpha., F.sub.1.beta., 11 deoxy E.sub.1, 11 deoxy F.sub.1.beta., and 11 deoxy F.sub.1.alpha. prostaglandins. The prostaglandins of this invention are variously useful as antithrombic agents, bronchodilators such as in the treatment of asthma, inhibitors of gastric secretion and as antihypertensive agents. Certain of the prostaglandins disclosed herein are useful as precursors for prostaglandins having one or more of the foregoing utilities.

  本发明公开了E.sub.1、A.sub.1、F.sub.1.alpha.、F.sub.1.beta.、11去氧E.sub.1、11去氧F.sub.1.beta.和11去氧F.sub.1.alpha.前列腺素的trans 1和2-二(较低烷基)膦酸酯；1和2-氯、溴和碘；1和2-硫和1和2-氨基类似物。本发明的前列腺素可用作抗凝血剂、支气管扩张剂（如治疗哮喘）、胃酸分泌抑制剂和降压剂。本文所披露的某些前列腺素可用作具有上述一种或多种用途的前列腺素的前体。
• 10,11,15-Trihydroxyprostanoic acid
  申请人：May & Baker Limited

  公开号：US03933890A1

  公开（公告）日：1976-01-20

  Cyclopentane derivatives of the formula: ##SPC1## (wherein the R symbols represent hydrogen or alkyl, n represents 4 or 6, and the symbols A, B, X and Y have any one of the following combinations: (a) A represents methylene, B represents hydroxymethylene, X represents ethylene and Y represents hydroxymethylene; (b) A represents carbonyl, B represents methylene, X represents ethylene or trans-vinylene and Y represents hydroxymethylene or carbonyl; or (c) A represents hydroxymethylene, B represents methylene, X represents ethylene or trans-vinylene and Y represents hydroxymethylene) are new compounds, possessing pharmacological properties, in particular, the production of hypotension, bronchodilatation, inhibition of gastric acid secretion and stimulation of uterine contraction.

  公式为：##SPC1##的环戊烷衍生物，其中R代表氢或烷基，n代表4或6，符号A、B、X和Y具有以下任意一种组合：(a) A代表亚甲基，B代表羟甲基，X代表乙烯基，Y代表羟甲基；(b) A代表羰基，B代表亚甲基，X代表乙烯基或顺式-乙烯基，Y代表羟甲基或羰基；或(c) A代表羟甲基，B代表亚甲基，X代表乙烯基或顺式-乙烯基，Y代表羟甲基，是具有药理作用的新化合物，特别是具有降压、支气管扩张、抑制胃酸分泌和刺激子宫收缩的作用。
• Cyclopentane derivatives and their pharmaceutical compositions
  申请人：May & Baker Limited

  公开号：US04171375A1

  公开（公告）日：1979-10-16

  Cyclopentane derivatives of the formula: ##STR1## wherein R.sup.1 represents hydrogen or a carboxylic acyl group, R.sup.2 represents hydrogen or alkyl of 1 through 12 carbon atoms, and n represents an integer from 4 through 8, are new compounds possessing pharmacological properties, more particularly the production of hypertension and inhibition of gastric acid secretion. They are also useful in the preparation of 10-hydroxyprostaglandins.

  公式为：##STR1##的环戊烷衍生物，其中R.sup.1代表氢或羧酸酰基，R.sup.2代表1到12个碳原子的氢或烷基，n代表4到8的整数，是具有药理学性质的新化合物，更具体地是产生高血压和抑制胃酸分泌。它们还可用于制备10-羟基前列腺素。